Lotus Eye Hospital And Institute Limited reported a net profit of ₹8.04 lakh for the financial year ended March 31, 2026, a sharp decline of 89% from ₹73.93 lakh in the previous year. The company's revenue from operations for the year rose to ₹5,371.41 lakh from ₹4,956.25 lakh in FY25. For the quarter ended March 31, 2026, the company recorded a net loss of ₹31.95 lakh compared to a net profit of ₹25.23 lakh in the corresponding period of the previous year, primarily impacted by a surge in finance costs.

The Board of Directors, at its meeting held on May 26, 2026, approved the standalone audited financial results for the quarter and year ended March 31, 2026. M/s. Anbarasu & Jalapathi, Chartered Accountants, the statutory auditors, issued an audit report with an unmodified opinion. The board also reappointed Mr. P Vishnu Adithan, Chartered Accountant, as the Internal Auditor of the company for the financial year 2026-27.

Financial Performance

The company's total income for FY26 stood at ₹5,489.03 lakh, up from ₹5,086.38 lakh in the previous year. Total expenses increased to ₹5,493.98 lakh from ₹4,949.10 lakh. Finance costs for the year surged to ₹85.92 lakh from ₹35.50 lakh in FY25. The basic earnings per share (EPS) for the year dropped to ₹0.04 from ₹0.36 in the previous year.

Operational Highlights

Exceptional items for the year amounted to a loss of ₹0.41 lakh, compared to a gain of ₹0.98 lakh in the previous year. The company's profit before tax for the year was a loss of ₹5.36 lakh, down from a profit of ₹138.26 lakh in FY25. The board meeting commenced at 05:15 PM and concluded at 06:00 PM on May 26, 2026. The intimation was made in compliance with Regulation 30, 33 and other applicable provisions of the SEBI (LODR) Regulations, 2015.

Pursuant to Regulation 47 of the SEBI (LODR) Regulations, 2015, the company published newspaper advertisements in the Business Standard (All India Edition) and The Tamil Hindu (Coimbatore Edition) on May 27, 2026, regarding the standalone audited financial results approved by the Board.

Lotus Eye Hospital And Institute Limited has filed its quarterly compliance certificate with stock exchanges and depositories, confirming adherence to SEBI regulations for securities dematerialization during Q4FY26.

Regulatory Compliance Certificate

The company submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, dated April 06, 2026. This quarterly filing covers the period ended March 31, 2026, ensuring transparency in the dematerialization process.

Dematerialization Process Confirmation

The certificate confirms that securities received for dematerialization have been properly processed according to regulatory requirements. Key compliance aspects include:

• Securities mutilated and cancelled after due verification
• Depository name substituted in company records as registered owner
• Process completed within 15 days of certificate receipt
• Details furnished to stock exchanges as required

Stock Exchange Listing Compliance

Lotus Eye Hospital confirmed that dematerialized securities remain listed on the same stock exchanges where earlier issued securities are traded. This ensures continuity of trading and maintains investor access to the company's shares.

Registrar Verification

MUFG Intime India Private Limited, serving as the company's Registrar and Share Transfer Agent, provided certification supporting the compliance filing. The registrar confirmed proper handling of securities received from depository participants during the quarter, with appropriate acceptance or rejection procedures followed.

The filing was signed by Prathish S, Company Secretary & Compliance Officer, demonstrating the company's commitment to maintaining regulatory standards and protecting investor interests through proper dematerialization procedures.